Pharmaceutical services partner Bend Bioscience has added a commercial-scale spray dryer and dry granulation system to its Gainesville facility.
The 120,000 sqft Georgia-based site will now be better equipped to provide drug products with both good absorbability and bioavailability, allowing the comprehensive production of clinical and commercial-scale oral dosage forms.
Featuring GEA's PSD-4, the new spray drying suite will include adjacent secondary vacuum drying systems, multiple tank sizes to accommodate flexible campaigns and batch sizes, a dual-stage condenser capable of handling a wide range of process solvents and the ability to process highly potent APIs.
The new equipment is being shipped to the Gainesville facility this month and the installation process will begin immediately to align with potential customer timelines.
"Our FDA-inspected Gainesville site is known for its exceptional customer service, and these latest additions demonstrate our commitment to providing strong, innovative, and comprehensive solutions that empower our customers to bring their transformative therapies to market,” said Owen Murray, CEO of Bend Bioscience.
“This expansion not only reinforces our position as a leader in the pharmaceutical services industry, but also allows us to meet the demands of significant near-term growth through our network of capabilities and expertise in enhancing pharmacokinetics, particle engineering and modified release forms.”
These new capabilities complement the company’s clinical development expertise in spray dried dispersions at its site in Bend, Oregon.
Through this expansion, Bend Bioscience will be able to support both existing and new early-phase customers seeking bioavailability solutions and oral dose forms — from early-phase development to commercial supply.
Bend's Gainesville facility specialises in oral solid dosage forms — acting as a centre of excellence for OSD commercial manufacturing, modified release and multiparticulates.
Equipped to handle DEA schedule (I-V) and potent compounds, the site is also home to analytical and late-phase tech transfer teams, as well as specialist packaging capabilities.